(Q58229242)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Duration of short-course androgen suppression therapy and the risk of death as a result of prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

James W Denham

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1

Anthony V D'Amico

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Ming-Hui Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Juanita Crook

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Shawn Malone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Allison Steigler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Mary Dunne

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

John G Armstrong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

31 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Oncology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

4682-4687

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

NCCN clinical practice guidelines in oncology: prostate cancer

15 January 2020

cites work

1 reference

12 December 2020

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

1 reference

12 December 2020

Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy

1 reference

12 December 2020

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

12 December 2020

Duration of androgen suppression in the treatment of prostate cancer

1 reference

12 December 2020

A Randomized Trial (Irish Clinical Oncology Research Group 97-01) Comparing Short Versus Protracted Neoadjuvant Hormonal Therapy Before Radiotherapy for Localized Prostate Cancer

1 reference

12 December 2020

Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial

1 reference

12 December 2020

Prostate cancer and the Will Rogers phenomenon.

1 reference

12 December 2020

Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.

1 reference

12 December 2020

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

1 reference

12 December 2020

Radiotherapy and short-term androgen deprivation for localized prostate cancer.

1 reference

12 December 2020

Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy

1 reference

12 December 2020

Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer.

1 reference

12 December 2020

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.

1 reference

12 December 2020

Contemporary risk profile of prostate cancer in the United States

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2011.37.0726

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22042952%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference